Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ABLi Therapeutics Logo
ABLi Therapeutics Growth Score
83
CB Rank
33198
Heat Score
71
ABLi Therapeutics is a biotechnology company that develops small-molecule therapeutics for neurodegenerative diseases.
PrivateFunding Round Atlanta, Georgia, United States11-50 www.ablitherapeutics.com
Biotechnology
Clinical Trials
Therapeutics
Overview

ABLi Therapeutics
Total Funding
obfuscation
Growth Score
83
Heat Score
71

Total Funding
obfuscation
obfuscation
Funding Round raised
obfuscation
Growth Score83
-11 pts
in past quarter
Heat Score 71
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About ABLi Therapeutics

CB Rank
33198
ABLi Therapeutics is a biotechnology company that develops small-molecule therapeutics for neurodegenerative diseases.
PrivateFunding Round Atlanta, Georgia, United States11-50 www.ablitherapeutics.com
Biotechnology
Clinical Trials
Therapeutics

Funding Rounds

Funding Round
OBF
in
obfuscation

Key People

  • Photo of Milton Werner
    Milton Werner: Founder and CEO
    Past Role: Inhibikase Therapeutics, Founder, President and CEO

Details

Legal Name ABLi Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Contact Email info@ablitherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

Risvodetinib (ABLi-148009)
An oral small-molecule c-Abl kinase inhibitor designed to modify Parkinson’s disease progression by targeting underlying biological mechanisms in the brain and gastrointestinal tract.
ABLi-0901
A small-molecule c-Abl kinase inhibitor in preclinical development targeting Parkinson’s disease, Dementia with Lewy Body, and Multiple System Atrophy.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round
obfuscation
Funding Round - ABLi Therapeutics Logo
Funding Round - ABLi Therapeutics
—
obfuscation
— Funding Round

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•May 6, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 20, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 28, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

348

Total IP

1ABLi Therapeutics has 1 registered trademark in the 'Scientific and technological services' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is ABLi Therapeutics's headquarters? ABLi Therapeutics is located in Atlanta, Georgia, United States.When was the last funding round for ABLi Therapeutics? ABLi Therapeutics closed its last funding round on
obfuscation
from a Undisclosed round.Who are ABLi Therapeutics's competitors? Alternatives and possible competitors to ABLi Therapeutics may include Bristol-Myers Squibb, Annovis Bio, and  Denali Therapeutics.How much funding has ABLi Therapeutics raised to date? ABLi Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(3a5fd92 1)
|